
Dexcom Stelo
No prescription required
Our Verdict
The most accessible CGM available — FDA-cleared, no prescription, Dexcom biosensor technology at approximately $99/month. The minimal app lacks meal scoring, coaching, and advanced analytics found in Levels or Nutrisense, making it best for self-sufficient users who want raw glucose data without platform overhead.
Affiliate link - we may earn a commission
Last updated: October 2026
Pros
- G7-based clinical accuracy
- 15-day sensor wear time
Cons
- Simpler app than wellness CGMs
Best For
- First-time CGM users who want to try glucose monitoring without a subscription commitment
- Self-sufficient health trackers comfortable interpreting raw glucose data independently
- Budget-conscious users seeking the low-cost Dexcom path to CGM data without a prescription
- People who want a no-prescription, no-hassle OTC glucose monitoring experience
Not Ideal For
- Users who want guided insights, meal scoring, or coaching (Levels or Nutrisense are better)
- Those seeking weight-loss-specific CGM programming (Signos is more targeted)
- Users who need data sharing with third-party health platforms (limited export options)
In-Depth Review
What Is the Dexcom Stelo?
The Dexcom Stelo is the first FDA-cleared over-the-counter continuous glucose monitor, allowing anyone to purchase and use a CGM without a prescription, as long as they're 18 or older and don't use insulin. Made by Dexcom — the company that has led the diabetes CGM market for over two decades with its G-series sensors — the Stelo brings Dexcom's glucose sensing technology to the general wellness consumer.
Launched in 2024, the Stelo represents a significant shift in the CGM landscape. Previously, non-diabetic consumers who wanted CGM data had to go through subscription platforms like Levels or Nutrisense, which handled the prescription process on their behalf. The Stelo eliminates that intermediary entirely: order online or pick it up at a pharmacy, apply the sensor, and start tracking glucose within 30 minutes. This direct-to-consumer accessibility has opened continuous glucose monitoring to a far broader audience than the subscription model ever reached.
How It Works
Each Dexcom Stelo sensor lasts 15 days and costs approximately $49, putting the monthly cost at roughly $99 for continuous monitoring (two sensors per month). The sensor is applied to the back of the upper arm with a spring-loaded applicator — a thin filament sits just under the skin to measure interstitial glucose levels. Readings are transmitted every five minutes via Bluetooth to the Stelo companion app on your smartphone.
The Stelo uses the same glucose oxidase biosensor technology that powers Dexcom's prescription G7 sensor, adapted for the OTC market. In Dexcom's pivotal study, the prescription G7 had a MARD of about 8.2% on the arm; Dexcom hasn't published a Stelo-specific figure we could verify. The key regulatory difference is that the Stelo is cleared for non-insulin-using individuals and is not intended to make treatment decisions for diabetes management. The app displays real-time glucose values, trend arrows indicating direction and velocity of glucose change, and basic daily summaries. However, it is intentionally simpler than the subscription platforms — there is no meal scoring, no dietitian access, no AI-powered coaching, and no food logging integration.
Key Features
- No prescription required: The first FDA-cleared OTC CGM, available for direct consumer purchase without physician involvement, health questionnaire, or pharmacy coordination
- Dexcom biosensor quality: Uses the same core glucose oxidase technology as the prescription Dexcom G7 (G7 MARD about 8.2% in Dexcom's pivotal study; no Stelo-specific figure published)
- 15-day sensor wear: Each sensor lasts two full weeks, with a simple one-button application process and a 30-minute warm-up period — shorter than Abbott Libre's 60-minute wait
- Real-time glucose with trend arrows: Five-minute readings with directional indicators showing whether glucose is rising, falling, or stable, along with velocity information showing how fast levels are changing
- Low barrier to entry: At approximately $99/month with no subscription commitment, no long-term contract, and no prescription, the lowest-friction path to continuous glucose monitoring
Interested in Dexcom Stelo?
Check the latest pricing and availability from the official store.
View Best PriceWhat Published Research and Owner Reviews Say
We haven't tested the Dexcom Stelo ourselves. This summary is based on Dexcom's published specifications, peer-reviewed studies where they exist, and owner reviews.
The Bottom Line
The Dexcom Stelo is the best entry point into continuous glucose monitoring for anyone who wants CGM data without the commitment or cost of a subscription platform. Its OTC availability, Dexcom's proven sensor quality, and the lowest ongoing cost in the category make it the most accessible CGM on the market. The tradeoff is a deliberately minimal software experience — you get the data, but interpreting and acting on it is entirely up to you. Ideal as a low-cost first CGM experience, a periodic check-in tool for users who have already learned their patterns, or a raw data source for those who prefer to analyze glucose trends on their own terms.
Frequently Asked Questions
Common questions about this topic
Ready to try Dexcom Stelo?
See the latest pricing and availability.
View Best PriceAffiliate link - we may earn a commission
Compare Dexcom Stelo
See how Dexcom Stelo stacks up against the competition
Related Products
Links may be affiliate links